Comparative Self-collection for Cervical Cancer Screening Pivotal Study
Mel Mont Medical · NCT07758140
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 25–65 · Women only
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 260
- US sites recruiting
- 11
- Study start
- July 9, 2026
- Record last updated
- August 11, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
To evaluate whether individuals drawn from the intended use population can successfully interpret and follow the IFU for the Mia by XytoTest self-collection device and perform a vaginal sample collection yielding sufficient cellular material for primary hrHPV screening.
To assess the clinical performance of Mia self-collected vaginal specimens by evaluating agreement with paired clinician-collected cervical specimens for the detection of high-risk HPV, when both specimen types are analyzed using the cobas HPV Test (Roche Molecular Systems). Residual samples may be used to determine adequacy for additional assays that require vaginal and/or cervical specimens (such as mRNA E6 and E7 Biomarker Test, dual stain cytology).
Being studied: Mia by XytoTest; Rovers Cervex-Brush
Conditions: HPV; HPV - Anogenital Human Papilloma Virus Infection
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
Group 1: General Population Group
- Participants are 25 to 65 years of age and willing to provide informed consent.
- Participants have an intact cervix.
Group 2: Enriched Population Group
- Participants are 25 to 65 years of age and willing to provide informed consent.
- Participants have an intact cervix.
- One or more of: prior diagnosis of hrHPV within previous 6 months; abnormal cervical Pap cytology result of HSIL or higher (HSIL, AIS, or invasive carcinoma per the Bethesda 2014 system) within previous 6 months; and/or presenting for colposcopy/LEEP/excisional intervention.
Exclusion Criteria
Apply to all groups
- Impaired decision-making capacity or inability to provide informed consent.
- History of partial or total hysterectomy, including removal of the cervix.
- Cervical tissue alteration or surgery within 5 months prior (conization, LEEP, laser ablation, or cryotherapy).
- Current pregnancy (based on self-reporting).
- Active menstruation at time of specimen collection.
- Vaginal bleeding within 48 hours.
- Have had sex or used tampons, creams, or other vaginal products in the last 48 hours.
- Participation in another clinical study that, in the investigator's opinion, would interfere with the results of this study.
- Any medical reason that, in the investigator's opinion, would disqualify the participant for a routine pelvic exam with cervical sample collection.
Recruiting US locations
ASR Arizona CGA
Phoenix, AZ 85004
Site contact: Reena Grewal · 208-906-1600 · reena@idahoasr.com
Integrated Clinical Research
Sherman Oaks, CA 91403
Site contact: Iryna McCormick · 818-861-0088 · i.mccormick@icrsite.com
Altus Clinical Research
Lake Worth, FL 33461
Site contact: Stephanie Feliz · 561-641-0404 · sfeliz@altusresearch.com
Zenacare Research
North Miami Beach, FL 33169
Site contact: Paola Rothberg · 305-902-3135 · paola@zenacare.com
ASR Idaho CGI
Boise, ID 83702
Site contact: Stephanie Canning · 208-906-1600 · stephaniec@idahoasr.com
Boeson Research - Great Falls
Great Falls, MT 59405
Site contact: Katie Davis · 406-564-1775 · katie@boesonresearch.com
Unified Women's Clinical Research
Raleigh, NC 27607
Site contact: Cassie Harris · 919-788-4449 · cassie.harris@unifiedhc.com
Innovo-Wilmington Health
Wilmington, NC 28401
Site contact: Erin Funk · 910-362-4040 · rfunk@wilmingtonhealth.com
Lyndhurst Clinical Research (Unified)
Winston-Salem, NC 27103
Site contact: Amie Butler · 336-765-9350
El Centro de Corazon
Houston, TX 77012
Site contact: Amabely Hernandez · 832-488-8210 · ahernandez@clinicagenbio.com
National Eagle Research
Lynnwood, WA 98036
Site contact: Samiee Shokati · 206-775-0598 · sshokati@nationaleagleresearch.com
Study contacts (from the official record)
- Liliana Montes · 305 335 6162 · l.montes@xytotest.com
- Rowena Schokman · 301-641-3215 · rschokman@mdcassoc.com
Similar studies in Arizona
All healthy volunteers studies in Arizona →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Developing Biomarkers of Dietary Intake: Dose Dependent Measurement of Sugar Intake
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Location
- Phoenix, AZ
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
A Phase I Study to Investigate the Effect of Hepatic Impairment of AZD9550 and AZD6234
AstraZeneca
- Location
- Chandler, AZ + 2 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingHealthy volunteersPhase 1
A Phase 1 Relative Bioavailability Study of a VX-581 Tablet Formulation
Vertex Pharmaceuticals Incorporated
- Location
- Tempe, AZ
- Eligibility basics
- Ages 18–55 · Men only
- RecruitingHealthy volunteersPhase 1
A Single and Multiple Ascending Dose Study of EPX-100 in Healthy Adult Participants
Epygenix
- Location
- Tempe, AZ
- Eligibility basics
- Ages 18–55